Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.
作者信息
Fuks J Z, Van Echo D A, Aisner J, Von Hoff D, Wiernik P H
出版信息
Cancer Treat Rep. 1981 Jan-Feb;65(1-2):133-4.
PMID:6261947
Abstract
摘要
相似文献
1
Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.
Cancer Treat Rep. 1981 Jan-Feb;65(1-2):133-4.
2
A phase II trial of m-AMSA in patients with small-cell lung cancer.
Cancer Clin Trials. 1981 Winter;4(4):393-5.
3
Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.
Cancer Treat Rep. 1980 Feb-Mar;64(2-3):345-7.
4
Phase II evaluation of AMSA in patients with metastatic lung cancer.
Cancer Treat Rep. 1980;64(12):1383-5.
5
Phase II study of AMSA in lung cancer.
Cancer Treat Rep. 1981 Jul-Aug;65(7-8):655-8.
6
Phase II evaluation of amsacrine in small cell lung cancer: a Southeastern Cancer Study Group trial.
Cancer Treat Rep. 1985 Mar;69(3):333-4.
7
Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.
Cancer Treat Rep. 1984 Jun;68(6):923-4.
8
Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
Cancer Treat Rep. 1980 Aug-Sep;64(8-9):1009-10.
9
Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Cancer Treat Rep. 1983 Feb;67(2):197-8.
10
Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
Cancer Treat Rep. 1983 Apr;67(4):391-2.
Zotero 插件